NCT06742138 To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE3
NCT06371534 A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults Status RECRUITING Phase PHASE1